These modifications can be written by METTL3 or METTL14 and can be erased by ALKBH5 and regulate the tumorigenesis of leukemia, pancreatic cancer, endometrial cancer and gastric cancer [10, 30, 44–46]. Here, ALKBH5 is linked to familial pancreatic carcinoma.